BRCA2 germline mutations in Swedish breast cancer families

被引:20
|
作者
Chen, JD
Hedman, MZ
Arver, BW
Sigurdsson, S
Eyfjörd, JE
Lindblom, A [1 ]
机构
[1] Karolinska Inst, S-17176 Stockholm, Sweden
[2] Iceland Canc Soc, Mol & Cell Biol Res Lab, Reykjavik, Iceland
关键词
hereditary breast cancer; breast cancer susceptibility gene; BRCA2; cancer family; gene mutation; familial breast cancer; mutations screening;
D O I
10.1038/sj.ejhg.5200167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [1] BRCA2 germline mutations in Swedish breast cancer families
    Jindong Chen
    Moraima Zelada Hedman
    Brita Wasteson Arver
    Stefan Sigurdsson
    Jorunn Erla Eyfjörd
    Annika Lindblom
    European Journal of Human Genetics, 1998, 6 : 134 - 139
  • [2] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [3] Japanese late-onset breast cancer families: Their clinicopathological characteristics and absence of BRCA1 and BRCA2 germline mutations
    Okumura T.
    Fukutomi T.
    Tsuda H.
    Kanai Y.
    Ushijima T.
    Akashi-Tanaka S.
    Nanasawa T.
    Breast Cancer, 1998, 5 (3) : 251 - 254
  • [4] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
    K Claes
    B Poppe
    I Coene
    A De Paepe
    L Messiaen
    British Journal of Cancer, 2004, 90 : 1244 - 1251
  • [5] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
    Claes, K
    Poppe, B
    Coene, I
    De Paepe, A
    Messiaen, L
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1244 - 1251
  • [6] Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
    Hikmat Abdel-Razeq
    Amal Al-Omari
    Farah Zahran
    Banu Arun
    BMC Cancer, 18
  • [7] Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
    Abdel-Razeq, Hikmat
    Al-Omari, Amal
    Zahran, Farah
    Arun, Banu
    BMC CANCER, 2018, 18
  • [8] Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
    Juan Zhang
    Renguang Pei
    Zhiyuan Pang
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Yuntao Xie
    Breast Cancer Research and Treatment, 2012, 132 : 421 - 428
  • [9] Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
    Zhang, Juan
    Pei, Renguang
    Pang, Zhiyuan
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 421 - 428
  • [10] High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
    Maksimenko, J.
    Irmejs, A.
    Trofimovics, G.
    Berzina, D.
    Skuja, E.
    Purkalne, G.
    Miklasevics, E.
    Gardovskis, J.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2018, 16